Additionally, pazopanib resulted in enhanced proliferation and fewer apoptotic events in 786-O or 769-P cells with RNF43 knockdown than in control ccRCC cells (Figs. 4d and 4e; Suppl. The gene discussed is RNF43; the disease is nonpapillary renal cell carcinoma.